Anti-tumor activity and its mechanism of lycopene.

Journal of International Oncology ›› 2013, Vol. 40 ›› Issue (4): 264-267.

Previous Articles Next Articles

Anti-tumor activity and its mechanism of lycopene.

HAN Jing, LING Zhi-Qiang

Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, Hangzhou 310022, China

Online:2013-04-08 Published:2013-03-27
Contact: LING Zhi-Qiang E-mail:lingzq@hotmail.com

Abstract

Abstract: Lycopene is an important natural carotenoid, and is widely found in human tissues and blood, with the prevention of many types of cancer, anti-aging effect. It can inhibit the proliferation of cancer cells of oral malignancy, and increasing of gap-junction communication between cells to prevent oral cancer occur, and also can inhibit the development of colorectal cancer by reducing the activity of matrix metalloproteinase. It plays the role of anti-metastatic through enhancing the expression of anti-metastatic gene nm23-H1.

Key words: font-size: 12pt, mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体" lang="EN-US">Neoplasms, Lycopene

HAN Jing, LING Zhi-Qiang. Anti-tumor activity and its mechanism of lycopene.[J]. Journal of International Oncology, 2013, 40(4): 264-267.

[1]	Tian Jing,Yuan Xiaofen,Han Yang,Ren Xia,Zhang Zhiyong,Guo Qiang,Li Lianlian,Zhang Xiaoyu,Zhang Zhen,Li Xia,Jiang Guosheng. Expression change of nm23-H1 in differentiation process of leukemia cells and its molecular mechanisms [J]. Journal of International Oncology, 2017, 44(4): 246-250.
[2]	. Characteristics and clinical values of SPECT/CT whole body bone scanning in detecting bone metastases in patients with lung adenocarcinoma or squamous cell carcinoma [J]. Journal of International Oncology, 2015, 42(6): 407-409.
[3]	. Analysis of surgical treatment effects for 240 cases with early esophageal carcinoma [J]. Journal of International Oncology, 2015, 42(6): 419-421.
[4]	ZHUANG Yan, LIU Li-Gen. JAK/STAT pathway and its role in acute leukemia [J]. Journal of International Oncology, 2014, 41(6): 460-463.
[5]	JIANG Xiao, XIA Juan, CHENG Bin. Chemokine CCL18 and tumor [J]. Journal of International Oncology, 2014, 41(10): 724-726.
[6]	CHEN Ke-Jun, LYU Shu-Qing . Resistant mechanism about rapamycin and solution [J]. Journal of International Oncology, 2014, 41(10): 740-743.
[7]	ZHAO Yan, FU Chun, FENG Xiao-Yan, WANG Xiang-Quan. Research of magnetic resonance spectroscopy on cervical cancer [J]. Journal of International Oncology, 2013, 40(6): 465-468.
[8]	WANG Qian, XIE Ping. Effects of ceramideinduced apoptosis on oncotherapy [J]. Journal of International Oncology, 2013, 40(11): 811-814.
[9]	GU Peng, YANG Dong-Rong. Contradictory effect and its mechanism of storeoperated calcium channel in cancer cells [J]. Journal of International Oncology, 2013, 40(11): 814-816.
[10]	LONG Cheng, JIANG Yong-Mei, LI Guo-Quan. Application of selective cyclooxygenase-2 inhibitors in tumor radiotherapy [J]. Journal of International Oncology, 2013, 40(11): 820-823.
[11]	WU Fen-Ping, YANG Zhi-Xiong. Correlation between lysyl oxidase-like protein 2 and neoplasms and its mechanism [J]. Journal of International Oncology, 2012, 39(4): 246-248.
[12]	CHENG Yu-Sheng, XIA Jing-Yan, XU Feng. Polyinosinic-polycytidylic acid and tumor immunity [J]. Journal of International Oncology, 2012, 39(4): 252-254.
[13]	HE Li, TANG Xu-Dong. The anti-tumor mechanism of (-)-epigallocatechin-3-gallate [J]. Journal of International Oncology, 2012, 39(4): 255-259.
[14]	FENG Xiu, OU Yang-Jian, ZHOU Min. Gene mutations and the phenotype of BCR/ABL-negative myeloproliferative neoplasms [J]. Journal of International Oncology, 2012, 39(4): 307-310.
[15]	WAN Shan, GU Kang-Sheng. Antiangiogenic therapy for PTCL [J]. Journal of International Oncology, 2012, 39(3): 190-193.

Anti-tumor activity and its mechanism of lycopene.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments